← Leaderboards
Glenn Swartz
Advanced Bioscience Laboratories, Inc.
$1,044,520
Attributed
$1,044,520
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $367.1K · FY2016–24$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,044,520 · 1
By mechanism
N01$1,044,520 · 1
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Ranajit Pal$45,474,422
- Timothy Fouts$52,990,932
- Peter Silvera$18,392,128
- Thomas Vancott$47,641,448
- Nancy Lin$35,254,825
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalLicensurePreventTechnologyMicrobicideAids PreventionUnited States National Institutes Of HealthResearch Clinical TestingPreventionSexual Hiv TransmissionNational Institute Of Allergy And Infectious DiseasePrevention StrategyClinical TrialsPreventive VaccineHiv InfectionsAcquired Immunodeficiency SyndromePlayPre-Exposure ProphylaxisResourcesServicesProduct DevelopmentEvaluationNovel TherapeuticsDevices
Grant awards (13)
Ovine Model and Vaginal Microbiome Support for HIV Non-vaccine Biomedical Prevention Product Development$2,998
N01 · FY2024 · AI · contact PI
Advancing Development of Multipurpose Prevention Technologies (MPTs)$8,001
N01 · FY2023 · AI · contact PI
Statistical Support for HIV Non-vaccine Biomedical Prevention Product Development$8,744
N01 · FY2022 · AI · contact PI
Ovine Model and Vaginal Microbiome Support for HIV Non-vaccine Biomedical Prevention Product Development$6,658
N01 · FY2022 · AI · contact PI
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY$96,463
N01 · FY2020 · AI · contact PI
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY$93,679
N01 · FY2019 · AI · contact PI
OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT.$85,069
N01 · FY2019 · AI · contact PI
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY$90,977
N01 · FY2018 · AI · contact PI
OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT.$83,017
N01 · FY2018 · AI · contact PI
STATISTICAL SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT$197,747
N01 · FY2017 · AI · contact PI
MATERIAL RECEIPT, STORAGE, SHIPPING AND INVENTORY$88,357
N01 · FY2017 · AI · contact PI
OVINE MODEL AND VAGINAL MICROBIOME SUPPORT FOR HIV NONVACCINE BIOMEDICAL PREVENTION PRODUCT DEVELOPMENT.$80,999
N01 · FY2017 · AI · contact PI
IGF::OT::IGF PLANNING AND IMPLEMENTATION OF A NIAID CONSULTATION: ADVANCING DEVELOPMENT OF MULTIPURPOSE PREVENTION TECHNOLOGIES (MPT).$201,811
N01 · FY2016 · AI · contact PI